Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Genetic analysis in young-age-of-onset Graves' disease reveals new susceptibility loci.

Brown RS, Lombardi A, Hasham A, Greenberg DA, Gordon J, Concepcion E, Hammerstad SS, Lotay V, Zhang W, Tomer Y.

J Clin Endocrinol Metab. 2014 Jul;99(7):E1387-91. doi: 10.1210/jc.2013-4358. Epub 2014 Mar 31.

2.

Use of Tag single nucleotide polymorphisms (SNPs) to screen PTPN21: no association with Graves' disease.

Zeitlin AA, Heward JM, Brand OJ, Newby PR, Franklyn JA, Gough SC, Simmonds MJ.

Clin Endocrinol (Oxf). 2006 Sep;65(3):380-4.

PMID:
16918960
3.

Fine mapping of loci linked to autoimmune thyroid disease identifies novel susceptibility genes.

Tomer Y, Hasham A, Davies TF, Stefan M, Concepcion E, Keddache M, Greenberg DA.

J Clin Endocrinol Metab. 2013 Jan;98(1):E144-52. doi: 10.1210/jc.2012-2408. Epub 2012 Nov 1.

4.

Association between interleukin 21 and Graves' disease.

Jia HY, Zhang ZG, Gu XJ, Guo T, Cui B, Ning G, Zhao YJ.

Genet Mol Res. 2011 Oct 31;10(4):3338-46. doi: 10.4238/2011.October.31.6.

5.

Association of 4p14 and 6q27 variation with Graves disease: a case-control study and a meta-analysis of available evidence.

Li FM, Liu L, Pang LN, Shen M, Lu HW, Zhang XH, Chu X, Song ZJ.

BMC Med Genet. 2017 May 18;18(1):56. doi: 10.1186/s12881-017-0406-7.

6.

Genetic association between IL-17F gene polymorphisms and the pathogenesis of Graves' Disease in the Han Chinese population.

Guo T, Huo Y, Zhu W, Xu F, Liu C, Liu N, Cao M, Cui B, Ning G.

Gene. 2013 Jan 10;512(2):300-4. doi: 10.1016/j.gene.2012.10.021. Epub 2012 Oct 27.

PMID:
23111159
7.

Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset.

Skórka A, Bednarczuk T, Bar-Andziak E, Nauman J, Ploski R.

Clin Endocrinol (Oxf). 2005 Jun;62(6):679-82.

PMID:
15943829
8.

Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.

Yin X, Latif R, Bahn R, Tomer Y, Davies TF.

Thyroid. 2008 Nov;18(11):1201-6. doi: 10.1089/thy.2008.0098.

9.

Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations.

Bednarczuk T, Hiromatsu Y, Fukutani T, Jazdzewski K, Miskiewicz P, Osikowska M, Nauman J.

Eur J Endocrinol. 2003 Jan;148(1):13-8.

10.

Differences in Gene-Gene Interactions in Graves' Disease Patients Stratified by Age of Onset.

Jurecka-Lubieniecka B, Bednarczuk T, Ploski R, Krajewska J, Kula D, Kowalska M, Tukiendorf A, Kolosza Z, Jarzab B.

PLoS One. 2016 Mar 4;11(3):e0150307. doi: 10.1371/journal.pone.0150307. eCollection 2016.

11.

Both interleukin-23A polymorphism and serum interlukin-23 expression are associated with Graves' disease risk.

Jia H, Tao F, Liu C, Guo T, Zhu W, Wang S, Cui B, Ning G.

Cell Immunol. 2015 Mar;294(1):39-43. doi: 10.1016/j.cellimm.2015.01.015. Epub 2015 Feb 3.

PMID:
25670394
12.

Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.

Villanueva R, Inzerillo AM, Tomer Y, Barbesino G, Meltzer M, Concepcion ES, Greenberg DA, MacLaren N, Sun ZS, Zhang DM, Tucci S, Davies TF.

Thyroid. 2000 Sep;10(9):791-8.

PMID:
11041456
13.

Genetic association of Fc receptor-like glycoprotein with susceptibility to Graves' disease in a Chinese Han population.

Fang Y, Li Y, Zeng J, Wang J, Liu R, Cao C.

Immunobiology. 2016 Jan;221(1):56-62. doi: 10.1016/j.imbio.2015.08.002. Epub 2015 Aug 18.

PMID:
26321232
14.

Polymorphisms in the interleukin 3 gene show strong association with susceptibility to Graves' disease in Chinese population.

Chu X, Dong C, Lei R, Sun L, Wang Z, Dong Y, Shen M, Wang Y, Wang B, Zhang K, Yang L, Li Y, Yuan W, Wang Y, Song H, Jin L, Xiong M, Huang W.

Genes Immun. 2009 Apr;10(3):260-6. doi: 10.1038/gene.2009.3. Epub 2009 Mar 5.

PMID:
19262575
15.

L-selectin gene polymorphisms in Graves' disease.

Chen HY, Cui B, Wang S, Zhao ZF, Sun H, Zhao YJ, Li XY, Ning G.

Clin Endocrinol (Oxf). 2007 Jul;67(1):145-51. Epub 2007 Apr 25.

PMID:
17465998
16.

Association of HLA-DR, -DQ genotype and CTLA-4 gene polymorphism with Graves' disease in Japanese children.

Iwama S, Ikezaki A, Kikuoka N, Kim HS, Matsuoka H, Yanagawa T, Sato H, Hoshi M, Sakamaki T, Sugihara S.

Horm Res. 2005;63(2):55-60. Epub 2005 Jan 3.

PMID:
15640608
17.

Foxp3 gene polymorphisms and haplotypes associate with susceptibility of Graves' disease in Chinese Han population.

Zheng L, Wang X, Xu L, Wang N, Cai P, Liang T, Hu L.

Int Immunopharmacol. 2015 Apr;25(2):425-31. doi: 10.1016/j.intimp.2015.02.020. Epub 2015 Feb 21.

PMID:
25708657
18.

Refined association of TSH receptor susceptibility locus to Graves' disease in the Chinese Han population.

Liu BL, Yang SY, Liu W, Xue LQ, Chen X, Pan CM, Gu ZH, Zhan M, Zhang XM, Liang J, Gao GQ, Du WH, Yuan GY, Ying R, Zhao SX, Song HD.

Eur J Endocrinol. 2014 Jan 1;170(1):109-19. doi: 10.1530/EJE-13-0517. Print 2014 Jan.

19.

The association of interleukin-1alpha and interleukin-1beta polymorphisms with the risk of Graves' disease in a case-control study and meta-analysis.

Liu N, Li X, Liu C, Zhao Y, Cui B, Ning G.

Hum Immunol. 2010 Apr;71(4):397-401. doi: 10.1016/j.humimm.2010.01.023. Epub 2010 Feb 8.

PMID:
20116409
20.

Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy.

Yin X, Latif R, Bahn R, Davies TF.

Thyroid. 2012 Jul;22(7):730-6. doi: 10.1089/thy.2012.0007. Epub 2012 Jun 4.

Supplemental Content

Support Center